A.I Could Create New Drugs Faster Than Any Human Team
Atomwise, a San Francisco-based startup and Y Combinator alum, has built a system it calls AtomNet (pdf), which attempts to generate potential drugs for diseases like Ebola and multiple sclerosis.
Atomwise's system only generates potential drugs the compounds created by the neural network aren't guaranteed to be safe, and need to go through the same drug trials and safety checks as anything else on the market.
The company believes that the speed at which it can generate trial-ready drugs based on previous safe molecular interactions is what sets it apart.
"You can take an interaction between a drug and huge biological system and you can decompose that to smaller and smaller interactive groups.
To generate the drugs, the model starts with a 3D model of a molecule for example a protein that gives a cancer cell a growth advantage.
Discover, Learn and Evaluate AI Companies and Solutions
The latest updates from AI companies in your industry
Get a weekly newsletter with the latest posts directly from the AI companies. Follow companies to tailor your feed.
JEDAI PRODUCT SUITE
Anagog provides a solution suite that offers to mobile app owners the most cost-effective, end-to-end, customer engagement solution.
Experience the leading AI demand forecasting platform.
SPELL - HYPERPARAMETER SEARCHES
Optimize hyperparameters to improve the accuracy of your model with the Spell Hyper command
SPELL - JUPYTER NOTEBOOK SERVER - GPU POWERED
Collaborative Jupyter Notebook or JupyterLab workspace server with powerful GPUs
SPELL - DEEP LEARNING PLATFORM
The fastest and most powerful end-to-end platform for machine learning and deep learning.